Public-benefit institution (launching)
Appears in 1 story
Being established by Kate Adamala and colleagues
Roche stopped making tRNA in 2023; Sigma stopped in 2024. With the only two commercial sources of a critical molecule gone, a small research group in San Francisco built its own factory to make the missing ingredients.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
